JW CAYMAN THERAPEUTICS CO LTD. revenue breakdown overview

JW CAYMAN THERAPEUTICS CO LTD. revenue for the last year amounted to 24.49 M USD, the most of which — 24.60 M USD — came from its highest performing source at the moment, Anti-tumor Drugs, the year earlier bringing 21.69 M USD. The greatest contribution to the revenue figure was made by China — last year it brought JW CAYMAN THERAPEUTICS CO LTD. 24.60 M USD, and the year before that — 21.69 M USD.